Data / Drug companies / Levothyroxine sodium
Levothyroxine sodium: 44 companies and 565 products in the FDA NDC directory
Levothyroxine sodium is listed in the FDA National Drug Code Directory by 44 companies, with 565 products in commercial distribution. 321 of the products (56.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule; solution, and the newest product started marketing on July 6, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 44
- Products
- 565
- Generic (ANDA) products
- 321 (56.8%)
- Application numbers
- 19
- Routes
- Oral, Intravenous
- Brand names
- Tirosint, Tirosint Sol, Synthroid, Unithroid, Levoxyl, Thyquidity
- openFDA record search
- api.fda.gov
Companies that list levothyroxine sodium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 74 | tablet | Generic drugs (ANDA) | April 8, 2025 |
| Bryant Ranch Prepack | 46 | tablet | Generic drugs (ANDA) | December 21, 2022 |
| Northwind Health Company, LLC | 35 | tablet | Generic drugs (ANDA) | March 30, 2023 |
| Ibsa Pharma Inc. | 30 | capsule; solution | New drug applications (NDA) | March 1, 2023 |
| Preferred Pharmaceuticals Inc. | 28 | tablet | Generic drugs (ANDA) | April 20, 2026 |
| NuCare Pharmaceuticals,Inc. | 18 | tablet | Generic drugs (ANDA) | April 8, 2025 |
| Proficient Rx LP | 17 | tablet | New drug applications (NDA) | December 10, 2020 |
| Alvogen Inc. | 14 | tablet | New drug applications (NDA) | May 7, 2019 |
| Cardinal Health 107, LLC | 13 | tablet | Generic drugs (ANDA) | May 2, 2019 |
| Coupler LLC | 13 | tablet | Generic drugs (ANDA) | July 6, 2026 |
| Direct_Rx | 13 | tablet | New drug applications (NDA) | January 9, 2025 |
| Remedyrepack Inc. | 13 | tablet | Generic drugs (ANDA) | August 13, 2025 |
| AbbVie Inc. | 12 | tablet | New drug applications (NDA) | July 24, 2002 |
| Accord Healthcare Inc. | 12 | tablet | Generic drugs (ANDA) | December 10, 2020 |
| Amneal Pharmaceuticals LLC | 12 | tablet | New drug applications (NDA) | July 3, 2014 |
| Amneal Pharmaceuticals NY LLC | 12 | tablet | Authorized generics (NDA) | October 1, 2007 |
| Asclemed USA Inc. | 12 | tablet | Generic drugs (ANDA) | December 10, 2020 |
| Camber Pharmaceuticals, Inc. | 12 | tablet | Generic drugs (ANDA) | January 18, 2023 |
| Lannett Company, Inc. | 12 | tablet | Authorized generics (NDA) | August 3, 2020 |
| Lupin Pharmaceuticals, Inc. | 12 | tablet | Generic drugs (ANDA) | May 2, 2019 |
| Macleods Pharmaceuticals Limited | 12 | tablet | Generic drugs (ANDA) | December 21, 2022 |
| Proficient Rx LP | 12 | tablet | Generic drugs (ANDA) | September 21, 2022 |
| XLCare Pharmaceuticals, Inc. | 12 | tablet | Generic drugs (ANDA) | January 18, 2023 |
| Yaral Pharma Inc. | 12 | capsule | Authorized generics (NDA) | March 1, 2023 |
| American Health Packaging | 11 | tablet | Generic drugs (ANDA) | January 5, 2021 |
| NorthStar RxLLC | 11 | tablet | Generic drugs (ANDA) | April 8, 2025 |
| Pfizer Laboratories Div Pfizer Inc | 11 | tablet | New drug applications (NDA) | May 25, 2001 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 10 | tablet | New drug applications (NDA) | October 1, 2007 |
| Bryant Ranch Prepack | 9 | tablet | Authorized generics (NDA) | August 3, 2020 |
| Major Pharmaceuticals | 9 | tablet | Generic drugs (ANDA) | May 2, 2019 |
| Bryant Ranch Prepack | 7 | tablet | Authorized generics (NDA) | August 3, 2020 |
| Mylan Institutional Inc. | 6 | tablet | Generic drugs (ANDA) | February 26, 2007 |
| Aurobindo Pharma Limited | 5 | tablet | Generic drugs (ANDA) | July 16, 2024 |
| Fresenius Kabi USA, LLC | 5 | injection, solution | New drug applications (NDA) | May 29, 2018 |
| Teva Pharmaceuticals, Inc. | 5 | tablet | Generic drugs (ANDA) | September 21, 2022 |
| Mylan Institutional Inc. | 4 | tablet | Generic drugs (ANDA) | January 14, 2019 |
| Redpharm Drug | 3 | tablet | Generic drugs (ANDA) | December 10, 2020 |
| Zydus Pharmaceuticals USA Inc. | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 1, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | December 10, 2020 |
| Piramal Critical Care Inc | 2 | injection | Generic drugs (ANDA) | October 1, 2022 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, solution | New drug applications (NDA) | November 15, 2022 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | July 5, 2023 |
| Oliva Therapeutics, LLC | 1 | solution | New drug applications (NDA) | July 1, 2025 |
| Zydus Lifesciences Limited | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 1, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 510 | 90.3% |
| Capsule | 27 | 4.8% |
| Solution | 16 | 2.8% |
| Injection, solution | 6 | 1.1% |
| Injection, powder, lyophilized, for solution | 4 | 0.7% |
| Injection | 2 | 0.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 321 | 56.8% |
| New drug applications (NDA) | 161 | 28.5% |
| Authorized generics (NDA) | 83 | 14.7% |
Pharmacologic classes
| Class | Products |
|---|---|
| l-Thyroxine | 565 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.